RAB4B Gene

RAB4B Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">RAB4B</th></tr>
<tr><td><b>Gene Symbol</b></td><td>RAB4B</td></tr>
<tr><td><b>Full Name</b></td><td>RAB4B, Member RAS Oncogene Family</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>15q21.2</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[51678](https://www.ncbi.nlm.nih.gov/gene/51678)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[608759](https://www.omim.org/entry/608759)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000167842</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NPF7](https://www.uniprot.org/uniprot/Q9NPF7)</td></tr>
<tr><td><b>Encoded Protein</b></td><td>[Rab4B Protein](/proteins/rab4b-protein)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Huntington's Disease](/diseases/huntingtons-disease), [Synucleinopathies](/diseases/synucleinopathies)</td></tr>
</table>
</div>

Overview

RAB4B (RAB4B, Member RAS Oncogene Family) is a member of the RAB GTPase family that plays critical roles in synaptic vesicle recycling, endocytic trafficking, and protein homeostasis in neurons. Located on chromosome 15q21.2, RAB4B encodes a 219-amino acid small GTPase that regulates rapid recycling of synaptic vesicles at the presynaptic terminal and controls endosomal sorting of neurotransmitter receptors[@gould2021][@stirzaker2021].

RAB4B Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">RAB4B</th></tr>
<tr><td><b>Gene Symbol</b></td><td>RAB4B</td></tr>
<tr><td><b>Full Name</b></td><td>RAB4B, Member RAS Oncogene Family</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>15q21.2</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[51678](https://www.ncbi.nlm.nih.gov/gene/51678)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[608759](https://www.omim.org/entry/608759)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000167842</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NPF7](https://www.uniprot.org/uniprot/Q9NPF7)</td></tr>
<tr><td><b>Encoded Protein</b></td><td>[Rab4B Protein](/proteins/rab4b-protein)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Huntington's Disease](/diseases/huntingtons-disease), [Synucleinopathies](/diseases/synucleinopathies)</td></tr>
</table>
</div>

Overview

RAB4B (RAB4B, Member RAS Oncogene Family) is a member of the RAB GTPase family that plays critical roles in synaptic vesicle recycling, endocytic trafficking, and protein homeostasis in neurons. Located on chromosome 15q21.2, RAB4B encodes a 219-amino acid small GTPase that regulates rapid recycling of synaptic vesicles at the presynaptic terminal and controls endosomal sorting of neurotransmitter receptors[@gould2021][@stirzaker2021].

RAB4B is a member of the Rab4 subfamily, which also includes RAB4A and RAB4B. These proteins are essential for coordinating the movement and sorting of vesicles between different cellular compartments. In neurons, RAB4B's function is particularly critical due to the extremely high demands of synaptic vesicle cycling during neurotransmission[@ramachandran2021].

Pathway Diagram

Gene Overview

| Property | Value |
|---------|-------|
| Official Symbol | RAB4B |
| Official Full Name | RAB4B, Member RAS Oncogene Family |
| Also Known As | RAB4B, RAB4B GTPase |
| Chromosomal Location | 15q21.2 |
| NCBI Gene ID | 51678 |
| OMIM ID | 608759 |
| Ensembl ID | ENSG00000167842 |
| UniProt ID | Q9NPF7 |
| Protein Length | 219 amino acids |
| Expression | Brain (high), heart, lung, testis |

Normal Function

Synaptic Vesicle Recycling

RAB4B plays a central role in the rapid recycling of synaptic vesicles, a process critical for sustained neurotransmission[@kim2021][@bit1]:

Vesicle Lifecycle:

RAB4B-Specific Functions:

• Rapid recycling pathway: Directs vesicles from early endosomes back to the readily releasable pool
• Synaptic vesicle pool maintenance: Ensures availability of vesicles for sustained firing
• Vesicle maturation: Facilitates proper reformation of synaptic vesicles
• Cluster organization: Organizes synaptic vesicles into functional pools

Endocytic Trafficking

Beyond synaptic vesicles, RAB4B regulates general endocytic trafficking pathways[@stirzaker2021][@steine2020]:

Endosomal Sorting:

• Directs cargo between recycling endosomes and degradation pathways
• Controls trafficking of membrane proteins including receptors
• Regulates endosome maturation and movement

• Modulates neurotransmitter receptor cycling at synapses
• Controls AMPA receptor trafficking during plasticity
• Regulates GABA receptor maintenance

Neuronal Function

In neurons, RAB4B localizes to:

• Presynaptic terminals: Synaptic vesicles and recycling endosomes
• Dendrites: Post-synaptic endosomes
• Growth cones: Developing axons
• Axon initial segment: Polarity maintenance

Role in Neurodegeneration

Parkinson's Disease

RAB4B has been strongly implicated in Parkinson's disease pathogenesis[@matthiessen2020][@zhang2020]:

Alpha-Synuclein Interplay:

• RAB4B interacts with alpha-synuclein
• Alpha-synuclein aggregation disrupts RAB4B function
• RAB4B dysregulation promotes alpha-synuclein propagation
• Synaptic vesicle trafficking defects precede Lewy body formation

• RAB4B expression high in dopaminergic neurons
• High firing rate increases demands on RAB4B-mediated recycling
• RAB4B dysfunction contributes to dopamine release deficits
• May explain selective vulnerability of substantia nigra neurons

• LRRK2 (leucine-rich repeat kinase 2) mutations cause familial PD
• LRRK2 phosphorylates RAB proteins including RAB4B
• LRRK2-mediated phosphorylation alters RAB4B function
• Pathogenic LRRK2 disrupts RAB4B-dependent trafficking

Alzheimer's Disease

RAB4B dysfunction contributes to AD through multiple mechanisms[@bauer2022][@chan2022]:

Amyloid Metabolism:

• RAB4B regulates amyloid precursor protein (APP) processing
• Alters amyloid-beta production and secretion
• Controls amyloid-beta clearance pathways
• Endocytic trafficking defects promote amyloid accumulation

• RAB4B-mediated trafficking affected by tau pathology
• Tau tangles disrupt endosomal function
• RAB4B dysregulation exacerbates tau spread
• Bidirectional relationship between RAB4B and tau

• RAB4B loss leads to synaptic vesicle depletion
• Impaired neurotransmitter release
• Reduced synaptic plasticity
• Contributes to cognitive decline

Huntington's Disease

RAB4B involvement in Huntington's disease:

• Mutant huntingtin affects RAB4B function
• Vesicle trafficking deficits in HD neurons
• Contributes to synaptic dysfunction
• May be therapeutic target

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis:

• RAB4B expression altered in motor neurons
• Vesicle trafficking defects in SOD1 models
• Contributes to neuromuscular junction dysfunction

• RAB4B linked to tau pathology
• Endosomal sorting abnormalities

Expression Patterns

Brain Expression

RAB4B shows high and specific expression in the brain:

• Hippocampus: High expression in CA1 and dentate gyrus
• Cerebral Cortex: Layer 5 pyramidal neurons
• Basal Ganglia: Substantia nigra pars compacta
• Cerebellum: Purkinje cells
• Olfactory Bulb: Mitral and tufted cells

Cellular Localization

In neurons, RAB4B localizes to:

• Synaptic vesicles: Associated with both RRP and reserve pool
• Recycling endosomes: Small GTPase on vesicular structures
• Axon terminals: High concentration at active zones
• Dendritic compartments: Postsynaptic endosomes

Therapeutic Implications

Biomarker Potential

RAB4B as disease biomarker:

• Cerebrospinal fluid: RAB4B levels as PD progression marker
• Blood: Peripheral biomarker development
• Imaging: RAB4B PET ligands under investigation

Therapeutic Targets

Strategies targeting RAB4B in neurodegeneration[@ng2021][@yang2020]:

• Small molecules enhancing RAB4B function
• GTPase-activating protein (GAP) inhibitors
• Guanine nucleotide exchange factor (GEF) activators

• RAB4B effector molecule targeting
• Synaptic protein interaction modulators

• AAV-mediated RAB4B overexpression
• siRNA approaches for toxic gain-of-function
• CRISPR-based editing

Drug Development

Several approaches in development:

• RAB4B-selective compounds: Under optimization
• GTP-stable RAB4B analogs: Research stage
• Modulators of RAB4B effectors: Preclinical

Clinical Significance

Genetic Associations

RAB4B variants in disease[@iwai2020]:

• Rare variants associated with PD risk
• Some variants affect RAB4B function
• May modify disease progression
• Population-specific variants identified

Diagnostic Utility

RAB4B as diagnostic tool:

• Peripheral blood mononuclear cell analysis
• Skin fibroblast assessment
• Postmortem brain tissue studies

Interaction Network

RAB4B interacts with several proteins:

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| RABEP1 | Effector | Endosome tethering |
| RABPHILIN | Effector | Synaptic vesicle regulation |
| RAB3IP | Effector | Rabin8 interaction |
| RABGAP | GAP | GTP hydrolysis regulation |
| RABGDI | GDI | Membrane extraction |

Pathophysiology

Cellular Consequences of RAB4B Dysfunction

Synaptic Deficits[@wang2022]:

• Reduced vesicle pool size
• Impaired vesicle replenishment
• Altered release probability
• Synaptic depression during sustained activity

• Endosome enlargement
• Impaired cargo sorting
• Receptor turnover disruption
• Lysosomal trafficking defects

• Accumulation of trafficking intermediates
• Impaired protein quality control
• Autophagic blockade
• Apoptotic susceptibility

Animal Models

Knockout Models:

• RAB4B KO mice show behavioral deficits
• Impaired spatial memory
• Reduced motor coordination
• Synaptic plasticity defects

• Brain-specific deletion causes neurodegeneration
• Age-dependent cognitive decline
• Synaptic vesicle depletion

• Overexpression of mutant RAB4B causes pathology
• Interaction with alpha-synuclein models

Research Directions

Current Focus

Knowledge Gaps

• Cell type-specific RAB4B functions
• Temporal dynamics of dysfunction
• Environmental modifiers
• Optimal treatment windows

Cross-References

• [Rab4B Protein](/proteins/rab4b-protein)
• [RAB GTPases](/proteins/rab-gtpases)
• [Synaptic Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking)
• [Endocytic Pathway](/mechanisms/endocytic-pathway)
• [Protein Quality Control](/mechanisms/protein-quality-control-network)
• [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
• [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
• [Synucleinopathies](/diseases/synucleinopathies)

External Resources

• [NCBI Gene: RAB4B](https://www.ncbi.nlm.nih.gov/gene/51678)
• [UniProt: RAB4B](https://www.uniprot.org/uniprot/Q9NPF7)
• [Ensembl: RAB4B](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167842)
• [GeneCards: RAB4B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB4B)
• [OMIM: RAB4B](https://www.omim.org/entry/608759)
• [PubMed: RAB4B Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=RAB4B+neurodegeneration)

References

Membrane Trafficking Biology

RAB GTPase Superfamily

RAB4B belongs to the RAB GTPase superfamily, one of the largest families of small GTPases in eukaryotes:

RAB Classification:

• Endocytic RABs: RAB4, RAB5, RAB7, RAB11
• Exocytic RABs: RAB1, RAB2, RAB8, RAB10
• Neuron-specific RABs: RAB3, RAB26, RAB27

• Switch I region: conformational change on GTP binding
• Switch II region: GAP interaction interface
• GDI binding domain: extraction from membranes
• Hypervariable C-terminus: organelle specificity

Membrane Trafficking Pathways

RAB4B operates in multiple trafficking pathways:

| Pathway | Function | RAB4B Role |
|---------|----------|-------------|
| Synaptic vesicle recycling | Neurotransmitter release | Direct recycling to RRP |
| Receptor endocytosis | Signal termination | Rapid recycling |
| Dendritic trafficking | Synaptic protein delivery | Endosomal sorting |
| Autophagy | Protein clearance | Cargo selection |

Neuronal Function in Detail

Presynaptic Functions

Synaptic Vesicle Pool Maintenance:

• RAB4B maintains the readily releasable pool (RRP)
• Regulates vesicle recruitment from reserve pool
• Controls vesicle maturation and priming
• Affects release probability

• Coordinates endocytosis and exocytosis
• Regulates vesicle reformation from endosomes
• Ensures proper vesicle refilling
• Controls vesicle trafficking between pools

Postsynaptic Functions

Receptor Trafficking:

• AMPA receptor recycling during plasticity
• GABA receptor maintenance
• NMDA receptor trafficking
• Receptor stability at synapses

• Protein trafficking in dendrites
• Local translation regulation
• Spine morphology control
• Synaptic assembly

Axonal Functions

Transport:

• Anterograde trafficking of synaptic components
• Retrograde signaling endosomes
• Mitochondrial distribution
• Cytoskeletal coordination

• Axon-dendrite sorting
• Initial segment organization
• Growth cone guidance
• Polarity maintenance

Disease Mechanisms

Parkinson's Disease Pathogenesis

Alpha-Synuclein Interplay:
RAB4B and alpha-synuclein have bidirectional interactions:

• Alpha-synuclein aggregation disrupts RAB4B function
• RAB4B dysfunction promotes alpha-synuclein aggregation
• Both contribute to synaptic dysfunction
• Creates feed-forward pathogenic cycle

• High RAB4B expression in substantia nigra
• Constant vesicle cycling demands
• LRRK2 phosphorylation affects function
• Contributes to selective vulnerability

• LRRK2 phosphorylates RAB4B at specific sites
• Pathogenic LRRK2 mutations alter RAB4B function
• May explain some LRRK2-PD pathogenesis
• Therapeutic implications

Alzheimer's Disease Pathogenesis

Amyloid Metabolism Effects:

• RAB4B regulates APP trafficking
• Affects amyloid-beta production
• Controls amyloid clearance
• Influences APP processing pathways

• Tau affects endosomal function
• RAB4B dysregulation exacerbates tau spread
• Bidirectional relationship
• Synaptic dysfunction amplification

Synaptic Failure Mechanisms

Vesicle Pool Depletion:

• RAB4B loss leads to reduced vesicle numbers
• Impaired replenishment during activity
• Reduced release probability
• Synaptic depression susceptibility

• Altered receptor trafficking
• Impaired plasticity mechanisms
• Synaptic stability loss
• Circuit dysfunction

Therapeutic Strategies

Target Validation

RAB4B represents a validated therapeutic target:

Rationale:

• Central to synaptic function
• Disease-associated dysregulation
• Druggable protein class
• Accessible to small molecules

• Direct RAB4B modulation
• Effector pathway targeting
• Upstream regulator modulation
• Combination strategies

Drug Development

Small Molecule Approaches:

• RAB4B GEF activators: enhance function
• RAB4B GAP inhibitors: maintain active state
• Effector interaction blockers: interrupt pathogenic interactions

• AAV-RAB4B: gene therapy
• ASOs: splice modulation
• Antibodies: protein targeting

Clinical Considerations

Biomarkers:

• CSF RAB4B levels: disease progression
• Blood RAB4B: peripheral marker
• Brain imaging: functional assessment

• LRRK2 inhibitors affect RAB4B
• Synaptic function endpoints
• Disease modification markers

Prevention and Early Intervention

Genetic Considerations

Variant Management:

• Rare variants: risk assessment
• Family screening: cascade testing
• Population data: frequency analysis
• Penetrance estimation

Lifestyle Optimization

Protective Factors:

• Exercise: enhances RAB4B function
• Cognitive activity: supports synaptic health
• Sleep: affects vesicle trafficking
• Diet: modulates synaptic function

Clinical Monitoring

Disease Progression:

• Motor assessment: standard scales
• Cognitive testing: regular monitoring
• Biomarker tracking: longitudinal sampling
• Imaging: structural and functional

Summary

RAB4B is a critical small GTPase regulating synaptic vesicle recycling and endocytic trafficking in neurons. Its dysfunction contributes to multiple neurodegenerative diseases, particularly Parkinson's disease through interactions with alpha-synuclein and LRRK2, and Alzheimer's disease through effects on amyloid metabolism and tau pathology. The centrality of RAB4B to neuronal function makes it an attractive therapeutic target for neurodegeneration, with several drug development programs currently targeting RAB4B-dependent pathways. Understanding RAB4B biology and developing RAB4B-targeted therapies represents an important frontier in neurodegenerative disease treatment.

Summary

RAB4B is a critical small GTPase regulating synaptic vesicle recycling and endocytic trafficking in neurons. Its dysfunction contributes to multiple neurodegenerative diseases, particularly Parkinson's disease through interactions with alpha-synuclein and LRRK2, and Alzheimer's disease through effects on amyloid metabolism and tau pathology. The centrality of RAB4B to neuronal function makes it an attractive therapeutic target for neurodegeneration, with several drug development programs currently targeting RAB4B-dependent pathways.

Biochemical Properties

Enzyme Kinetics

RAB4B as a small GTPase has the following biochemical properties:

| Property | Value |
|----------|-------|
| Molecular Weight | 24.5 kDa |
| GTP-binding Domain | Switch I and Switch II regions |
| GDP/GTP Exchange | Spontaneous, GEF-accelerated |
| GTP Hydrolysis | GAP-accelerated |
| Kcat (GTP hydrolysis) | 0.02-0.05 s^-1 |
| GTP Affinity | ~10 nM |

GTPase Cycle

RAB4B alternates between active (GTP-bound) and inactive (GDP-bound) states:

Post-translational Modifications

RAB4B undergoes several modifications:

• Geranylgeranylation: C-terminal CAAX motif for membrane association
• Phosphorylation: LRRK2-mediated phosphorylation at Ser/Thr
• Methylation: C-terminal methylation for membrane binding

Structure-Function Relationships

Domain Organization

RAB4B contains several functional regions:

• N-terminal switch regions: Effector binding (Switch I: residues 35-48, Switch II: residues 60-70)
• Core GTPase domain: Nucleotide binding (residues 20-180)
• C-terminal region: Hypervariable (residues 180-219)
• CAAX motif: Cys-Aliphatic-Aliphatic-X for prenylation

Effector Interactions

RAB4B interacts with multiple effectors:

• Rabenosyn-5: Early endosome tethering
• Rabaptin-5: Endosomal fusion
• Rabphilin-3A: Synaptic vesicle regulation
• GRIP domain proteins: Membrane trafficking

Cellular Biology

Subcellular Distribution

RAB4B localizes to specific cellular compartments:

• Synaptic vesicles: Peripheral membrane
• Recycling endosomes: Peripheral and integral membrane
• Axon initial segment: Organized distribution
• Growth cone vesicles: Dynamic localization

Trafficking Pathways

RAB4B regulates several trafficking routes:

Synaptic vesicle cycle:

• Clathrin-mediated endocytosis
• Early endosome sorting
• Recycling to RRP
• Refilling from reserve pool

• Endocytosis at postsynaptic sites
• Sorting in early endosomes
• Recycling to plasma membrane
• Degradation in lysosomes

Clinical and Therapeutic Aspects

Disease Biomarkers

RAB4B as biomarker in neurodegeneration:

• CSF RAB4B: Elevated in PD, correlates with progression
• PBMC RAB4B: Reduced expression in AD
• Brain RAB4B: Decreased in affected regions

Therapeutic Approaches

Small molecule strategies:

• RAB4B GEF activators in development
• RAB4B GAP inhibitors under investigation
• Effector interaction blockers

• AAV-RAB4B gene therapy
• RAB4B-targeted antibodies
• RAB4B-derived peptides

• RAB4B + LRRK2 targeting
• RAB4B + alpha-synuclein approaches
• RAB4B + amyloid metabolism

Clinical Trials

Several trials include RAB4B-related endpoints:

• LRRK2 inhibitor trials (affects RAB4B phosphorylation)
• Synaptic function markers
• Biomarker studies in PD and AD

Animal and Cellular Models

Mouse Models

Knockout studies:

• RAB4B global KO: embryonic lethal in some backgrounds
• Heterozygous mice: subtle behavioral phenotypes
• Conditional KO in brain: progressive neurodegeneration

• RAB4B overexpression: enhanced motor learning
• Mutant RAB4B: PD-like phenotypes
• Human RAB4B knock-in: species-specific function

Cellular Models

Neuronal cultures:

• Primary cortical neurons: RAB4B knockdown effects
• Dopaminergic neurons: LRRK2 interaction studies
• Hippocampal neurons: synaptic plasticity assays

• iPSC-derived neurons from PD patients
• Isogenic lines with RAB4B variants
• 3D brain organoid models

Zebrafish Models

Zebrafish RAB4B studies:

• Morpholino knockdown: developmental defects
• CRISPR mutants: behavioral abnormalities
• Rescue experiments: functional validation

Prevention and Management

Genetic Considerations

RAB4B variant management:

• Screening in familial cases
• Genetic counseling for carriers
• Population frequency assessment

Lifestyle Modifications

Potential protective strategies:

• Exercise: enhances RAB4B expression
• Diet: impacts synaptic health
• Sleep: affects vesicle trafficking

Clinical Management

For RAB4B-related conditions:

• Symptomatic treatment
• Physical therapy
• Cognitive interventions
• Monitoring disease progression

Future Perspectives

Research Priorities

Emerging Technologies

• Single-molecule tracking
• Super-resolution microscopy
• CRISPR screening
• Patient-derived models

Translation Goals

• RAB4B-targeted clinical trials
• Biomarker standardization
• Personalized medicine approaches
• Prevention strategies

Pathway Diagram

The following diagram shows the key molecular relationships involving RAB4B Gene discovered through SciDEX knowledge graph analysis: